Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00956579 · ClinicalTrials.gov registry record

Sensory and Connectivity Abnormalities in Autism Spectrum Disorders

A clinical trial, sponsored by Massachusetts General Hospital.

Completed
Registry status
85
Enrollment target

NCT00956579: Completed study, sponsored by Massachusetts General Hospital.

NCT00956579 is a clinical trial that has completed, run by Massachusetts General Hospital. The registered enrollment target is 85 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00956579 has completed, sponsored by Massachusetts General Hospital.

COMPLETED
Registry status
85 participants
Enrollment target

Study Summary

Study the neural substrates of autism spectrum disorders using neuroimaging methods such as MEG/EEG/MRI.

Trial Details

FieldValue
Enrollment Target 85 participants
Start Date 2013-06
Est. Completion 2025-06

Sponsor

Massachusetts General Hospital

2,032 total trials

What the Registry Record Tells You About NCT00956579

The ClinicalTrials.gov registry entry for NCT00956579 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 85 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT00956579 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00956579 about?

NCT00956579 is a clinical study titled "Sensory and Connectivity Abnormalities in Autism Spectrum Disorders". Study the neural substrates of autism spectrum disorders using neuroimaging methods such as MEG/EEG/MRI.

What is the current status of trial NCT00956579?

This trial is currently completed. The enrollment target is 85 participants. The study started on 2013-06. Estimated completion is 2025-06.

Who is sponsoring clinical trial NCT00956579?

This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.